Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Non-Current Assets (2020 - 2025)

Oncology Institute's Non-Current Assets history spans 6 years, with the latest figure at $51.9 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 13.91% year-over-year to $51.9 million; the TTM value through Dec 2025 reached $217.6 million, down 12.88%, while the annual FY2025 figure was $51.9 million, 13.91% down from the prior year.
  • Non-Current Assets reached $51.9 million in Q4 2025 per TOI's latest filing, down from $53.5 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $230.3 million in Q1 2021 to a low of $49.4 million in Q4 2021.
  • Average Non-Current Assets over 5 years is $99.8 million, with a median of $65.7 million recorded in 2023.
  • The largest YoY upside for Non-Current Assets was 165.77% in 2022 against a maximum downside of 71.05% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $49.4 million in 2021, then soared by 165.77% to $131.2 million in 2022, then tumbled by 49.91% to $65.7 million in 2023, then decreased by 8.29% to $60.3 million in 2024, then fell by 13.91% to $51.9 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Non-Current Assets are $51.9 million (Q4 2025), $53.5 million (Q3 2025), and $55.0 million (Q2 2025).